Optomed Plc: Interim report, January – September 2023
Optomed Plc Stock Exchange Release 3 November 2023 at 9:00, Helsinki Optomed Plc: Interim report, January – September 2023 July – September 2023 · Revenue increased by 14.0 percent to EUR 4.2 (3.7) million. · Devices segment revenue increased by 7.5 percent to EUR 1.8 (1.7) million due to increased distributor sales. · Software segment revenue increased by 19.4 percent to EUR 2.4 (2.0) million driven by strong healthcare solution sales. · Adjusted EBITDA amounted to EUR 0.3 (0.1) million corresponding to 6.2 (3.9) percent of revenue. EBITDA amounted to EUR -0.0 (0.1)